Indian Covid-19 vaccine ‘highly efficacious’, study finds
PARIS: Covaxin, the first Covid-19 vaccine developed in India, is “highly efficacious” and presents no safety concerns, according to a study published in the Lancet yesterday. Covaxin,
PARIS: Covaxin, the first Covid-19 vaccine developed in India, is “highly efficacious” and presents no safety concerns, according to a study published in the Lancet yesterday. Covaxin,